The Basics of Medicare for Ryan White HIV/AIDS Program Clients
Overview of Medicare eligibility and coverage for RWHAP clients and other people with HIV.
Resource updated 09/25/2023
Overview of Medicare eligibility and coverage for RWHAP clients and other people with HIV.
Resource updated 09/25/2023
Resource (Conference Presentation) updated 09/14/2023
Resource updated 09/19/2023
Overview of Medicare prescription drug coverage for RWHAP clients and other people with HIV.
Resource updated 11/02/2023
Resource updated 03/11/2024
Resource updated 03/11/2024
Resource updated 03/18/2024
Step-by-step description of the annual resource allocation process undertaken by the Philadelphia EMA for Ryan White Part A funds.
Resource updated 01/30/2024
Resource updated 10/04/2023
Resource updated 09/25/2023
Guidance on development of HIV/AIDS epidemiological profiles for use in planning/evaluation activities of both prevention and care programs.
Resource updated 12/04/2023
Description of how an agency is working to build and sustain their HIV workforce.
Resource updated 01/11/2021
People aging with HIV are at increased risk and experience an array of comorbidities including diabetes, cardiovascular disease, and neurocognitive impairment. This poster will demonstrate the implementation of Medicare Wellness Visits, outcome data and lessons learned.
Resource (Conference Presentation) updated 09/14/2023
Event updated 08/19/2022
Legislative and policy requirements for Part A and Part B on allocation of RWHAP funds.
Orientation guide for Part B Program Directors, staff and others.
Resource updated 11/02/2023
Manual for Ryan White Part A recipients and planning bodies on administration of their programs.
Resource updated 09/19/2023
Resource allocation requirements for Part A and Part B RWHAP recipients. Part of Resource Allocation Considerations for RWHAP Part A and Part B.
Analysis of optimal allocation of CDC and HRSA funding for HIV prevention services as well as RWHAP Part A and B expenditures on services for linkage to care, retention in care, and adherence to antiretroviral therapy.
Resource updated 01/30/2024